Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi-Lepri

Showing results (21-30 of 244) with videos related to

Pageof 25
Sort By:
The Journal of Infectious Diseases|July 20, 2005
Effect of hepatitis C virus genotype on CD4+ T cell count in a cohort of antiretroviral-naive HIV-1-infected individualsGiorgio Antonucci, Alessandro Cozzi-Lepri, Enrico Girardi, et al.
AIDS (London, England)|April 18, 2003
Theoretical rationale for the use of sequential single-drug antiretroviral therapy for treatment of HIV infectionAndrew N Phillips, Michael S Youle, Fiona Lampe, et al.
HIV Clinical Trials|April 30, 2016
Fosamprenavir/ritonavir in patients with viral hepatitis coinfection: an observational multicohort studyPaola Nasta, Dominique Salmon, Antonella d'Arminio Monforte, et al.
The Journal of Infectious Diseases|July 5, 2008
Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological responseLambert Assoumou, Françoise Brun-Vézinet, Alessandro Cozzi-Lepri, et al.
Journal of the International AIDS Society|November 14, 2014
Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practiceSilvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2007
Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?Marco Bongiovanni, Andrea Gori, Alessandro Cozzi Lepri, et al.
AIDS (London, England)|May 31, 2013
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatmentGiuseppe Lapadula, Alessandro Cozzi-Lepri, Giulia Marchetti, et al.
Plos One|May 2, 2015
Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in ItalyAlessandra Bandera, Andrea Gori, Francesca Sabbatini, et al.
Journal of the International AIDS Society|November 15, 2014
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failureAnna Schultze, Roger Paredes, Caroline Sabin, et al.
Antiviral Therapy|November 30, 2005
Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapyAlessandro Cozzi-Lepri, Lidia Ruiz, Clive Loveday, et al.
Pageof 25

Showing results (21-30 of 244) with videos related to

Sort By:
Pageof 25
The Journal of Infectious Diseases|July 20, 2005
Effect of hepatitis C virus genotype on CD4+ T cell count in a cohort of antiretroviral-naive HIV-1-infected individualsGiorgio Antonucci, Alessandro Cozzi-Lepri, Enrico Girardi, et al.
AIDS (London, England)|April 18, 2003
Theoretical rationale for the use of sequential single-drug antiretroviral therapy for treatment of HIV infectionAndrew N Phillips, Michael S Youle, Fiona Lampe, et al.
HIV Clinical Trials|April 30, 2016
Fosamprenavir/ritonavir in patients with viral hepatitis coinfection: an observational multicohort studyPaola Nasta, Dominique Salmon, Antonella d'Arminio Monforte, et al.
The Journal of Infectious Diseases|July 5, 2008
Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological responseLambert Assoumou, Françoise Brun-Vézinet, Alessandro Cozzi-Lepri, et al.
Journal of the International AIDS Society|November 14, 2014
Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practiceSilvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2007
Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?Marco Bongiovanni, Andrea Gori, Alessandro Cozzi Lepri, et al.
AIDS (London, England)|May 31, 2013
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatmentGiuseppe Lapadula, Alessandro Cozzi-Lepri, Giulia Marchetti, et al.
Plos One|May 2, 2015
Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in ItalyAlessandra Bandera, Andrea Gori, Francesca Sabbatini, et al.
Journal of the International AIDS Society|November 15, 2014
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failureAnna Schultze, Roger Paredes, Caroline Sabin, et al.
Antiviral Therapy|November 30, 2005
Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapyAlessandro Cozzi-Lepri, Lidia Ruiz, Clive Loveday, et al.
Pageof 25